About Haermonics
Haermonics is a company based in Amsterdam (Netherlands) founded in 2015.. Haermonics has raised $4.41 million across 1 funding round from investors including BOM, Demcon and Invest-NL. Haermonics offers products and services including Haermonics Laebroides. Haermonics operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Scinovia and ProCell, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.41 M (USD)
in 1 rounds
-
Latest Funding Round
$4.41 M (USD), Series A
Aug 02, 2022
-
Investors
BOM
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haermonics
Haermonics offers a comprehensive portfolio of products and services, including Haermonics Laebroides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for flushing pericardial space to prevent post-operative complications.
Funding Insights of Haermonics
Haermonics has successfully raised a total of $4.41M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.41 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.4M
-
First Round
First Round
(02 Aug 2022)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series A - Haermonics | Valuation | BOM , Demcon |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Haermonics
Haermonics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include BOM, Demcon and Invest-NL. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by BOM toward early and growth-stage firms.
|
Founded Year | Domain | Location | |
|
Infrastructure and venture capital funding is provided in key sectors.
|
Founded Year | Domain | Location | |
|
Health innovations are found, built, and scaled by NLC.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Haermonics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Haermonics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Haermonics Comparisons
Competitors of Haermonics
Haermonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Scinovia and ProCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hematology products and solutions are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| domain | founded_year | HQ Location |
Intraoperative autotransfusion devices are developed and provided.
|
|
| domain | founded_year | HQ Location |
Augmented-reality surgical cameras for blood flow visualization are developed.
|
|
| domain | founded_year | HQ Location |
Develops medical devices for intraoperative blood recovery and conservation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Haermonics
When was Haermonics founded?
Haermonics was founded in 2015 and raised its 1st funding round 7 years after it was founded.
Where is Haermonics located?
Haermonics is headquartered in Amsterdam, Netherlands.
Is Haermonics a funded company?
Haermonics is a funded company, having raised a total of $4.41M across 1 funding round to date. The company's 1st funding round was a Series A of $4.41M, raised on Aug 02, 2022.
What does Haermonics do?
Harmonics has developed a drainage and flushing system that allows the implementation of continuous postoperative pericardial flushing. It allows a controlled infusion of a warmed liquid solution into the pericardial cavity after the operation while the system monitors blood loss. Continuous flushing will result in a lower viscosity mixture that will prevent chest tubes from clogging and promote the evacuation of blood and clots from the pericardial cavity.
Who are the top competitors of Haermonics?
Haermonics's top competitors include Haemonetics, VISIE and Sisu Global Health.
What products or services does Haermonics offer?
Haermonics offers Haermonics Laebroides.
Who are Haermonics's investors?
Haermonics has 4 investors. Key investors include BOM, Demcon, Invest-NL, and NLC Health Ventures.